Title
Category
Credits
Event date
Cost
  • Oncology
  • ACPE Pharmacy
  • Participation
$0.00
Presented by Creative Educational Concepts, Inc. (CEC) and supported through independent educational grants from AstraZeneca and Daiichi Sankyo.
  • Oncology
  • ACPE Pharmacy
  • Participation
$0.00
Presented by Creative Educational Concepts, Inc. (CEC) and supported through an independent educational grant from Merck & Co., Inc.
  • Oncology
  • ACPE Pharmacy
  • Participation
$0.00
Participants will gain exposure to emerging clinical and scientific advances in the treatment of chronic lymphocytic leukemia (CLL) with BTK inhibitors (BTKis), including novel pharmacologic targets within the B-cell receptor (BCR) pathway, and the latest, top-line safety and efficacy trial data for BTK inhibitors in both treatment-naïve (TN) and relapsed/refractory (R/R) CLL. Prominent mechanisms of BTK inhibitor resistance and adaptive strategies used to prevent and/or mitigate the development of resistance also will be explored.
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
As the novel coronavirus, SARS-CoV-2, spreads across the globe, and as confirmed cases of COVID-19 infection continue to climb, we are being ushered into circumstances which are unprecedented in modern times. It is thus absolutely vital that cardiologists, who are tasked with managing a patient population with chronic cardiovascular disease (CVD) that is, resultantly, at high risk for severe manifestations of COVID-19, be informed regarding adaptive ways to maintain effective CVD disease management while also keeping their patients safe.
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
As the novel coronavirus, SARS-CoV-2, spreads across the globe, and as confirmed cases of COVID-19 infection continue to climb, we are being ushered into circumstances which are unprecedented in modern times. It is thus absolutely vital that oncology clinicians, who manage a patient population at very high risk for severe manifestations of COVID-19, be informed regarding adaptive ways to keep their patients safe. To help meet that need, this online educational activity will review the ever-changing epidemiology of COVID-19 and identify primary infection risk concerns for cancer patients.
  • Oncology
  • AMA PRA Category 1 Credit™
$0.00
  • Oncology
  • ACPE Pharmacy
  • Participation
$0.00
Presented by CEC Oncology and supported through an independent educational grant from AstraZeneca.
  • Psychiatry
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
The rapid onset of COVID-19 in the United States, combined with the dismantling of the spring 2020 medical conference infrastructure and widespread travel bans and social distancing has created a synchronous need in all clinical arenas to manage patients with pre-existing conditions, such as schizophrenia, who require management with LAIs. Join our expert faculty for this on-demand online activity, focusing on their expert insights into guiding patients, caregivers, and clinicians on using LAIs during the global health pandemic of COVID-19.

Pages